When good cholesterol goes bad

被引：50

作者：

Fogelman, AM ^{[1
]}

机构：

[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA

来源：

NATURE MEDICINE | 2004年 / 10卷 / 09期

关键词：

D O I：

10.1038/nm0904-902

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

High density lipoprotein (HDL) is often called the 'good cholesterol.' Products of an inflammatory enzyme, myeloperoxidase, are now shown to selectively target the main protein in HDL, apolipoprotein A-I. This turns the 'good cholesterol' bad.

引用

页码：902 / 903

页数：2

共 12 条

[1] Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment
Ansell, BJ
Navab, M
Hama, S
Kamranpour, N
Fonarow, G
Hough, G
Rahmani, S
Mottahedeh, R
Dave, R
Reddy, ST
Fogelman, AM
[J]. CIRCULATION, 2003, 108 (22) : 2751 - 2756
[2] Prognostic value of myeloperoxidase in patients with chest pain
Brennan, M
Penn, MS
Van Lente, F
Nambi, V
Shishehbor, MH
Aviles, RJ
Goormastic, M
Pepoy, ML
McErlean, ES
Topol, EJ
Nissen, SE
Hazen, SL
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (17) : 1595 - 1604
[3] Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol
Brousseau, ME
Schaefer, EJ
Wolfe, ML
Bloedon, LT
Digenio, AG
Clark, RW
Mancuso, JP
Rader, DJ
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15) : 1505 - 1515
[4] Increased immunolocalization of paraoxonase, clusterin, and apolipoprotein A-I in the human artery wall with the progression of atherosclerosis
Mackness, B
Hunt, R
Durrington, PN
Mackness, MI
[J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (07) : 1233 - 1238
[5] Navab M, 2000, J LIPID RES, V41, P1481
[6] Navab M, 2000, J LIPID RES, V41, P1495
[7] Oral D-4F causes formation of pre-β high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice
Navab, M
Anantharamaiah, GM
Reddy, ST
Hama, S
Hough, G
Grijalva, VR
Wagner, AC
Frank, JS
Datta, G
Garber, D
Fogelman, AM
[J]. CIRCULATION, 2004, 109 (25) : 3215 - 3220
[8] The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL
Navab, M
Ananthramaiah, GM
Reddy, ST
Van Lenten, BJ
Ansell, B
Fonarow, GC
Vahabzadeh, K
Hama, S
Hough, G
Kamranpour, N
Berliner, JA
Lusis, A
Fogelman, AM
[J]. JOURNAL OF LIPID RESEARCH, 2004, 45 (06) : 993 - 1007
[9] Oral administration of an apo A-I mimetic peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol
Navab, M
Anantharamaiah, GM
Hama, S
Garber, DW
Chaddha, M
Hough, G
Lallone, R
Fogelman, AM
[J]. CIRCULATION, 2002, 105 (03) : 290 - 292
[10] Navab M, 2001, J LIPID RES, V42, P1308

← 1 2 →